Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-30

Clinical Trial Update: Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing behavioral modification plus Vesicare (solifenacin) versus Vesicare alone for urge incontinence in adults with overactive bladder was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vesicare (solifenacin succinate)

Snippet

Sponsor: Lahey Clinic | Conditions: Overactive Bladder | Phase 3 | Status: TERMINATED | Results posted: 2010-07-30